Eudocia Lee
National Cancer Institute (NCI) · Dana-Farber Cancer Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Eudocia Lee as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:57 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03107780 · Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain CancerNational Cancer Institute (NCI) · terminated · Glioblastoma, Gliosarcoma, MGMT-Unmethylated Glioblastoma · principal investigator
- Ph2NCT02478164 · Trial of Ponatinib in Patients With Bevacizumab-Refractory GlioblastomaDana-Farber Cancer Institute · completed · Glioblastoma · principal investigator
- Ph2NCT00766467 · A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant GliomasEudocia Quant Lee, MD · completed · Malignant Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:57 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Alliance for Clinical Trials in Oncology Member Site CoreU10CA180821 · NCI · ALLIANCE NCTN FOUNDATION · PI Evanthia Galanis · fiscal years 2014 to 2026Named on NCT03107780
- Adult Brain Tumor Consortium (ABTC)UM1CA137443 · NCI · JOHNS HOPKINS UNIVERSITY · PI STUART A GROSSMAN · fiscal years 2014 to 2020Named on NCT03107780
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:57 UTC. The ranking covers the 200 most relevant of 891 PubMed records, and a shared surname and initials can bring in a namesake. All 891 on PubMed
- 1,693 citationsRCR 43.3
- Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy.N Engl J Med · 20171,507 citationsRCR 51.2
- 1,171 citationsRCR 43.0
- Tofacitinib or adalimumab versus placebo in rheumatoid arthritis.N Engl J Med · 2012792 citationsRCR 23.2
- 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.N Engl J Med · 2021778 citationsRCR 43.5
- Tofacitinib versus methotrexate in rheumatoid arthritis.N Engl J Med · 2014631 citationsRCR 20.3
- Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection.Gastroenterology · 2019224 citationsRCR 12.7
- Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.Lancet Diabetes Endocrinol · 2020190 citationsRCR 11.3
- 156 citationsRCR 7.5
- Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy.Epilepsia · 2016140 citationsRCR 6.7